M83.4
Aluminum bone disease
Clinical Classification Guidelines
Medical Intelligence & Overview
Aluminum Bone Disease, also known as aluminum-related osteodystrophy, is a condition characterized by abnormal bone mineralization caused by excessive accumulation of aluminum in the bones. This disorder often occurs in individuals with kidney failure undergoing long-term dialysis, where impaired kidney function leads to increased aluminum levels in the body. The buildup of aluminum interferes with normal bone formation, resulting in weakened bones that are prone to fractures and deformities. Recognizing the symptoms and understanding the causes of this disease are crucial for effective management and prevention, especially in at-risk populations.
Causes & Symptoms
Clinical Causes: Prolonged exposure to aluminum-containing medications or products Chronic kidney disease (CKD) leading to decreased aluminum clearance Use of aluminum-based phosphate binders in patients with kidney failure Increased absorption of aluminum from contaminated water or environment Dialysis procedures that do not effectively remove aluminum from the bloodstream
Key Symptoms: Bone pain or tenderness, especially in the hips, spine, and long bones Muscle weakness and fatigue Bone deformities or abnormalities, such as bowing or deformity of limbs Increased risk of fractures due to fragile bones Signs of uremia or worsening kidney function in advance stages
Diagnostic & Treatment
Diagnosis Path: Diagnosis usually involves a combination of blood tests, bone biopsies, and imaging studies. Blood tests may show elevated aluminum levels, abnormal levels of calcium and phosphate, and signs of secondary hyperparathyroidism. Bone biopsy remains the definitive test to confirm aluminum deposition in bones. Imaging techniques such as X-rays can reveal characteristic changes like osteomalacia or osteoporosis. Healthcare providers also evaluate the patient's medical history, especially their kidney function and any exposure to aluminum-containing products.
Treatment Protocols: Discontinuing or avoiding aluminum-containing medications and products Using chelating agents, such as deferoxamine, to bind and remove excess aluminum from the body Optimizing dialysis techniques to improve aluminum clearance Managing calcium and phosphate levels through dietary modifications and medications Providing vitamin D analogs or other bone-supportive therapies to improve bone mineralization Monitoring bone health regularly through imaging and laboratory tests
Clinical Advice & FAQs
Billing Guidance
Is M83.4 a billable ICD-10 code?
Yes, M83.4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M83.4?
Clinical documentation must specify the nature of Aluminum bone disease and any associated comorbidities for accurate reporting.
Cite this Clinical Reference